AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Illumina
ILMN
|
$464M |
| 2 |
Synopsys
SNPS
|
$441M |
| 3 |
Procter & Gamble
PG
|
$438M |
| 4 |
Dollar General
DG
|
$436M |
| 5 |
MSCI
MSCI
|
$414M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$825M |
| 2 |
Meta Platforms (Facebook)
META
|
$604M |
| 3 |
Nike
NKE
|
$524M |
| 4 |
Apple
AAPL
|
$431M |
| 5 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$343M |
Sector Composition
| 1 | Technology | 23.94% |
| 2 | Healthcare | 18.36% |
| 3 | Financials | 13.63% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Arbutus Biopharma
ABUS
$769M
| $114K | ﹤0.01% |
49,100
+17,300
| +54% | +$40.3K |
|
|
AKYA
3102
DELISTED
Akoya BioSciences
AKYA
| $113K | ﹤0.01% |
+11,800
| New | +$113K |
|
|
CYXT
3103
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
| $112K | ﹤0.01% |
58,500
+18,982
| +48% | +$36.4K |
|
3104
BuzzFeed
BZFD
$68.5M
| $110K | ﹤0.01% |
39,802
| – | – |
|
|
VLDR
3105
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $108K | ﹤0.01% |
145,900
+38,200
| +35% | +$28.2K |
|
3106
Future Fuel
FF
$172M
| $107K | ﹤0.01% |
13,217
+1,422
| +12% | +$11.6K |
|
3107
UNIFI
UFI
$81.2M
| $107K | ﹤0.01% |
12,400
-1,897
| -13% | -$16.3K |
|
3108
Relmada Therapeutics
RLMD
$45.5M
| $106K | ﹤0.01% |
30,400
+12,500
| +70% | +$43.6K |
|
|
SILV
3109
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $106K | ﹤0.01% |
17,652
| – | – |
|
|
MMX
3110
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $104K | ﹤0.01% |
22,260
| – | – |
|
3111
CleanSpark
CLSK
$2.55B
| $101K | ﹤0.01% |
49,300
+33,600
| +214% | +$68.5K |
|
|
ORLA
3112
Orla Mining
ORLA
$3.67B
| $99.4K | ﹤0.01% |
24,600
| – | – |
|
3113
NextNav
NN
$2.11B
| $95.5K | ﹤0.01% |
32,600
+12,400
| +61% | +$36.3K |
|
3114
Babcock & Wilcox
BW
$221M
| $94.6K | ﹤0.01% |
+16,400
| New | +$94.6K |
|
3115
Monte Rosa Therapeutics
GLUE
$303M
| $94.4K | ﹤0.01% |
+12,400
| New | +$94.4K |
|
3116
Tango Therapeutics
TNGX
$760M
| $94.3K | ﹤0.01% |
+13,000
| New | +$94.3K |
|
3117
RLX Technology
RLX
$3.12B
| $93.3K | ﹤0.01% |
+40,580
| New | +$93.3K |
|
3118
Rimini Street
RMNI
$406M
| $92.2K | ﹤0.01% |
24,200
+11,000
| +83% | +$41.9K |
|
|
WE
3119
DELISTED
WeWork Inc.
WE
| $92.2K | ﹤0.01% |
1,612
-1,311
| -45% | -$75K |
|
|
MAGN
3120
Magnera Corporation
MAGN
$425M
| $89.3K | ﹤0.01% |
2,470
+830
| +51% | +$30K |
|
|
ROVR
3121
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $86.6K | ﹤0.01% |
23,600
+11,400
| +93% | +$41.8K |
|
3122
Evolv Technologies
EVLV
$1.36B
| $86.5K | ﹤0.01% |
33,400
+5,600
| +20% | +$14.5K |
|
|
EXK
3123
Endeavour Silver
EXK
$1.78B
| $85.9K | ﹤0.01% |
26,500
| – | – |
|
|
DDL
3124
Dingdong
DDL
$442M
| $85.3K | ﹤0.01% |
+19,980
| New | +$85.3K |
|
|
CURO
3125
DELISTED
CURO Group Holdings Corp.
CURO
| $84.5K | ﹤0.01% |
23,800
+1,800
| +8% | +$6.39K |
|